Patient satisfaction is often claimed as a surrogate for healthcare quality. This is an incorrect and dishonest assertion and threatens to destroy the doctor-patient relationship at its most sacred juncture—the bedside.
Patient satisfaction is often claimed as a surrogate for healthcare quality. This is an incorrect and dishonest assertion and threatens to destroy the doctor-patient relationship at its most sacred juncture—the bedside.
In the early 2000s the federal government discovered a new metric, patient satisfaction, and mandated hospitals to begin measuring and reporting satisfaction survey results. A generous interpretation is that the CMS mandate is a misguided attempt to guarantee quality in the healthcare for which they were paying.
The cynical view is that the patient satisfaction mandate is an indirect way for the feds to reduce payment. In 2012, CMS began to tie satisfaction survey results to Medicare reimbursement; nearly a billion dollars in payments to hospitals that failed to meet patient satisfaction metrics were at stake in 2013. This created the equivalent of a dirty bomb explosion in the C-suite of most hospitals.
Link to the article on Medpage Today: http://bit.ly/1zIxvXF
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Similar In-Hospital, Long-Term Survival Rates Found Among Male, Female Patients With AECOPD
March 18th 2024This study analyzed sex differences among patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), with findings indicating that female smokers experience worse hospital outcomes despite similar overall survival rates.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
AstraZeneca joins efforts to address high drug prices by capping out-of-pocket costs for its inhalers; Opill, the first OTC birth control pill, is now accessible through online sales; expansion prompts questions on the effectiveness and regulation of remote monitoring technology.
Read More